Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

Tuesday’s trading has closed, but SGEN is being traded in the after-hours session. After-Hours quote »
29.04
Delayed Data
As of 3:59pm ET
 -0.31 / -1.06%
Today’s Change
28.04
Today|||52-Week Range
52.33
-35.29%
Year-to-Date

Today’s Trading

Previous close29.35
Today’s open28.59
Day’s range28.04 - 30.40
Volume2,236,215
Average volume (3 months)1,113,087
Market cap$4.1B
Dividend yield--
Data as of 3:59pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-52.17%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book17.26

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.06+0.78%
ALKSAlkermes Plc-0.39-1.32%
GRFSGrifols SA+0.13+0.90%
MDVNMedivation Inc+0.85+3.11%
Data as of 4:02pm ET, 02/09/2016

Financials

Next reporting dateFebruary 10, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts

Partner Offers